Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Interim Management Statement

12 May 2011 07:00

RNS Number : 4418G
Huntsworth PLC
12 May 2011
Β 

ο»Ώ

Β 

Β 

Β 

Β 

Β 

Β 

12 May 2011

Β 

Β 

Huntsworth plc

("Huntsworth" or "the Group")

Interim Management StatementΒ 

Β 

Huntsworth Wins Β£15m of New Business

Β 

Huntsworth issues this Interim Management Statement to cover the period from 1 January 2011 to date.

Β 

Huntsworth, the public relations and healthcare communications Group, has won over Β£15m of new business since reporting full year results six weeks ago including a 27 country mandate for the European Union, a 17 country programme for DHL, and, the newly acquired Atomic, has been awarded the largest win in its history.Β As a result of these and other contract wins, committed revenues for the Group are now approximately 80% of 2011 full year forecasts on a strongly rising revenue stream.

Β 

As reported at the full year, management expects revenues to be heavily second half weighted as these large accounts come on stream, underpinning our revenue expectations for 2011 and giving added confidence in 2012 organic growth targets.

Β 

The balance sheet remains robust with net debt comfortably within banking covenants.

Β 

Β 

Grayling

Β 

Following the 38 country win of British Airways announced in March, Grayling has seen increased client interest in its international capabilities. DHL, the international carrier company, has appointed Grayling in 17 countries and the European Union has appointed Grayling to handle a three year, six million euro, 27 member state anti-smoking campaignΒ and OMV, Central Europe's leading oil and gas supplier, has expanded its relationship into six countries.

Β 

Atomic has been awarded a seven figure fee account - the largest in its history - and has already made seven international pitches alongside their new Grayling colleagues.

Β 

Β 

Huntsworth Health

Β 

Huntsworth Health has been appointed by a top ten Pharma company to prepare for the launch of a novel new oncology product. Another top ten Pharma has added Huntsworth to its preferred supplier lists for global assignments in both medical education and medical communications. In addition Huntsworth Health was invited to participate as a member of a new independent network to pitch for 13 individual therapeutic categories at a top ten pharma.

Β Β 

Β 

Citigate

Β 

Citigate continues to build on its position as a leading M&A advisory consultancy and was recently ranked 5th globally by volume in the mergermarket league table. Current projects in the UK include transaction work for the London Stock Exchange, the Yorkshire Building Society and Chaucer Holdings. Internationally Citigate has won a number of new accounts, including the Malaysian Smelting Company and the state of Ontario, Canada in support of its international investment and trade programmes in China.

Β 

Β 

Red

Β 

RED has 90% of its 2011 budget committed and has added more blue chip names to its UK client list - including 20th Century Fox, Schweppes Abbey Well and Gatwick Airport.

Β 

Β 

Β 

Peter Chadlington, Huntsworth CEO, commented "As a direct result of the reorganisation of the Group, we are beginning to see real momentum throughout the Group as the number of global and international opportunities increase significantly. We are confident that we will meet management expectations for 2011 and believe that we are now on course for good organic growth in 2012."

Β Β 

Β 

Β 

Β 

Enquiries to:

Β 

Huntsworth PLC +44 (0)207 224 8778

Peter Chadlington, Chief Executive

Colin Adams, Group Finance Director

Β 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Simon Rigby

Angharad Couch

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSDKDDQKBKBCPD
Date   Source Headline
14th Dec 20122:22 pmRNSBoard Changes
3rd Dec 20123:41 pmRNSBlocklisting Interim Review
3rd Dec 20123:37 pmRNSTotal Voting Rights
15th Nov 20127:00 amRNSInterim Management Statement
14th Nov 20123:20 pmRNSDirector/PDMR Shareholding
7th Nov 201212:40 pmRNSAdditional Listing
22nd Oct 20123:55 pmRNSHolding(s) in Company
11th Oct 201210:03 amRNSScrip Dividend Alternative
25th Sep 20124:32 pmRNSHolding(s) in Company
3rd Sep 201211:32 amRNSTotal Voting Rights
24th Aug 201210:16 amRNSHolding(s) in Company
17th Aug 201211:06 amRNSAdditional Listing
15th Aug 20127:00 amRNSInterim Results
9th Aug 20127:00 amRNSNotice of Results
1st Aug 20129:08 amRNSTotal Voting Rights
30th Jul 201211:58 amRNSHolding(s) in Company
13th Jul 20125:29 pmRNSTransaction in Own Shares
6th Jul 201211:21 amRNSDirector/PDMR Shareholding
5th Jul 20127:00 amRNSDirectorate Change
5th Jul 20127:00 amRNSDirectorate Change
3rd Jul 20129:47 amRNSAdditional Listing
29th Jun 201211:30 amRNSShare Buy-back Programme
11th Jun 201211:52 amRNSScrip Dividend Alternative
1st Jun 20129:57 amRNSBlocklisting Interim Review
18th May 201211:16 amRNSResult of AGM
18th May 20127:00 amRNSAppointment of Non-Executive Director
18th May 20127:00 amRNSInterim Management Statement
2nd May 201210:34 amRNSAnnual Information Update
18th Apr 20129:07 amRNSNotice of AGM
4th Apr 20129:00 amRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSPreliminary Results
1st Feb 20129:30 amRNSTotal Voting Rights
31st Jan 20122:05 pmRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSPre Close Trading Statement
11th Jan 20127:00 amRNSTransaction in Own Shares
4th Jan 20129:18 amRNSTotal Voting Rights
21st Dec 20117:00 amRNSTransaction in Own Shares
20th Dec 20117:00 amRNSTransaction in Own Shares
19th Dec 20117:00 amRNSTransaction in Own Shares
15th Dec 20117:00 amRNSTransaction in Own Shares
14th Dec 20117:00 amRNSTransaction in Own Shares
5th Dec 20117:00 amRNSTransaction in Own Shares
2nd Dec 20117:00 amRNSTransaction in Own Shares
1st Dec 20119:28 amRNSBlocklisting Interim Review
1st Dec 20119:25 amRNSTotal Voting Rights
1st Dec 20117:00 amRNSTransaction in Own Shares
29th Nov 20117:00 amRNSTransaction in Own Shares
25th Nov 20117:00 amRNSTransaction in Own Shares
24th Nov 201110:00 amRNSAmendment: Transaction in Own Shares
24th Nov 20119:15 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.